International Clinical Trial: A Single-Arm Prospective Clinical Study of Senaparib as First-Line Maintenance Treatment in HRD-Negative Advanced Epithelial Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer

Geneva, Feb. 2 -- International Clinical Trials Registry received information related to the study (ChiCTR2600117429) titled 'A Single-Arm Prospective Clinical Study of Senaparib as First-Line Maintenance Treatment in HRD-Negative Advanced Epithelial Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer' on Jan. 23.

Study Type: Interventional study

Study Design: Single arm

Primary Sponsor: Sun Yat-sen University Cancer Center (Sun Yat-sen University Cancer Hospital, Sun Yat-sen University Cancer Research Institute)

Condition: Newly diagnosed and histopathologically confirmed epithelial ovarian cancer, fallopian tube cancer, and primary peritoneal cancer

Recruitment Status: Recruiting

Phase: N/A

Date of First Enrol...